Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a pause on dosing of Ixchiq, but the agency’s new safety alert is based on an assessment that found the vaccine appears to be causing chikungunya-like illness in recipients.
Chikungunya virus has been very much in the news recently. It is a virus that is transmitted to humans through mosquito bites. The most common symptoms of this virus are high fevers and joint pains but can also include headache, rash, diarrhea, and myalgias. At the end of 2013, it was the first time this […]
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.